Enterococcus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
Condition: Immunoglobulin Light-chain Amyloidosis Interventions: Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab; Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab Sponsor: Air Force Military Medical University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Phenotypic and Genotypic Variations of Enterococcus Spp
Conditions: Isolation of Enterococci From Samples; Demonstration of Enterococci Antibiotic Susceptibility; Detection of Strains Enterococci Produce Biofilm; Studying Effect of Nanoparticles on Enterococci Antimicrobial Resistance; Studying Effect of Nanoparticles on Enterococci Biofilm; Genotyping of Enterococci Interventions: Diagnostic Test: Culture; Diagnostic Test: Staining:; Diagnostic Test: Biochemical reactions:; Diagnostic Test: VITEK; Diagnostic Test: Antibiotic sensitivity test; Diagnostic Test: nanoparticles effect; Diagnostic Test: The biofilm...
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials